RAYMOND JAMES & ASSOCIATES – Amgen Inc. Transaction History
RAYMOND JAMES & ASSOCIATES portfolio value:
$207.41M
portfolio value
RAYMOND JAMES & ASSOCIATES quarter portfolio value change:
-7.36%
quarter
Amgen Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Increase | +11.97% | 98.38K shares | 7.46M | $225.4 | 920.16K |
Q2 2022 | share | Decrease | -1.13% | -9.37K shares | -1.05M | $243.3 | 821.78K |
Q1 2022 | share | Decrease | -1.06% | -8.92K shares | 12M | $241.82 | 831.16K |
Q4 2021 | share | Increase | +0.25% | 2.13K shares | 10.81M | $226.47 | 840.08K |
Q3 2021 | call | Decrease | -100.00% | -16.4K shares | -91K | $210.86 | 0 |
Q3 2021 | share | Decrease | -5.85% | -52.07K shares | -38.75M | $210.86 | 837.95K |
Q2 2021 | share | Decrease | -44.40% | -710.82K shares | -181.38M | $239.87 | 890.02K |
Q2 2021 | call | Decrease | -73.89% | -46.4K shares | -68K | $239.87 | 16.4K |
Q1 2021 | call | Increase | +375.76% | 49.6K shares | 144K | $243.15 | 62.8K |
Q1 2021 | share | Increase | +1.59% | 25.04K shares | 35.99M | $243.15 | 1.60M |
Q4 2020 | share | Decrease | -9.63% | -167.93K shares | -80.88M | $223.02 | 1.57M |
Q4 2020 | call | Decrease | -5.04% | -700 shares | 3K | $223.02 | 13.2K |
Q3 2020 | share | Increase | +7.49% | 121.46K shares | 60.59M | $244.88 | 1.74M |
Q3 2020 | call | Decrease | -3.47% | -500 shares | -37K | $244.88 | 13.9K |
Q2 2020 | share | Increase | +66.48% | 647.84K shares | 185.08M | $225.74 | 1.62M |
Q2 2020 | call | Decrease | -10.00% | -1.6K shares | 39K | $225.74 | 14.4K |
Q1 2020 | call | Decrease | -52.94% | -18K shares | -187K | $192.75 | 16K |
Q1 2020 | share | Increase | +11.27% | 98.68K shares | -13.57M | $192.75 | 974.43K |
Q4 2019 | share | Increase | +11.00% | 86.79K shares | 58.44M | $227.57 | 875.75K |
Q4 2019 | call | Increase | 0.00% | 34K shares | 197K | $227.57 | 34K |
Q3 2019 | share | Decrease | -0.09% | -725 shares | 7.14M | $181.47 | 788.96K |
Q2 2019 | share | Increase | +4.78% | 36.03K shares | 2.34M | $171.56 | 789.68K |
Q2 2019 | call | Decrease | -100.00% | -35.1K shares | -7K | $171.56 | 0 |
Q1 2019 | share | Decrease | -1.41% | -10.74K shares | -5.62M | $175.37 | 753.65K |
Q1 2019 | call | Increase | +12.50% | 3.9K shares | -12K | $175.37 | 35.1K |
Q4 2018 | share | Increase | +8.35% | 58.90K shares | 2.56M | $178.32 | 764.39K |
Q4 2018 | call | Decrease | -2.50% | -800 shares | 3K | $178.32 | 31.2K |
Q3 2018 | call | Decrease | -1.84% | -600 shares | 9K | $188.58 | 32K |
Q3 2018 | share | Decrease | -4.25% | -31.32K shares | 10.23M | $188.58 | 705.49K |
Q2 2018 | share | Increase | +4.38% | 30.90K shares | 15.66M | $166.81 | 736.81K |
Q2 2018 | call | Increase | 0.00% | 32.6K shares | 7K | $166.81 | 32.6K |
Q1 2018 | share | Increase | +8.58% | 55.80K shares | 7.29M | $152.9 | 705.90K |
Q4 2017 | share | Increase | +3.32% | 20.91K shares | -4.26M | $154.83 | 650.10K |
Q3 2017 | call | Decrease | -100.00% | -10.6K shares | -90K | $164.89 | 0 |
Q3 2017 | share | Increase | +2.88% | 17.61K shares | 11.98M | $164.89 | 629.19K |
Q2 2017 | share | Increase | +4.75% | 27.75K shares | 9.54M | $151.29 | 611.57K |
Q2 2017 | call | Decrease | -70.47% | -25.3K shares | 89K | $151.29 | 10.6K |
Q1 2017 | share | Increase | +4.86% | 27.07K shares | 14.38M | $143.09 | 583.81K |
Q1 2017 | call | Increase | 0.00% | 35.9K shares | 1K | $143.09 | 35.9K |
Q4 2016 | share | Increase | +3.85% | 20.63K shares | -8.02M | $126.65 | 556.73K |
Q4 2016 | call | Decrease | -100.00% | -38.3K shares | -163K | $126.65 | 0 |
Q3 2016 | share | Increase | +32.52% | 131.56K shares | 27.87M | $143.51 | 536.09K |
Q3 2016 | call | Increase | 0.00% | 38.3K shares | 163K | $143.51 | 38.3K |
Q2 2016 | share | Increase | +98.61% | 200.85K shares | 31.01M | $130.16 | 404.53K |
Q1 2016 | share | Decrease | -5.38% | -11.57K shares | -4.40M | $127.42 | 203.67K |